Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer
Hoffman, S.L.V., Mixdorf, J.C., Kwon, O., Johnson, T.R., Makvandi, M., Lee, H., Aluicio-Sarduy, E., Barnhart, T.E., Jeffery, J.J., Patankar, M.S., Engle, J.W., Bednarz, B.P., Ellison, P.A.
Published in Nuclear medicine and biology (01.07.2023)
Published in Nuclear medicine and biology (01.07.2023)
Get full text
Journal Article